← Evidence map

ArticleDiabetes care2017

Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390.

Kaiping Luo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390. | OpenQuestion